Elitech

The Elite InGenius has the sample prep capabilities typical of high-throughput platforms, yet it can run more samples than smaller instruments.

The fully automated system has 12 independent thermal cyclers and runs the firm's diagnostic kits, but it can also operate as an open instrument.

NEW YORK (GenomeWeb) – Integrated DNA Technologies said today it has obtained a license to manufacture and supply EliTech Group's MGB Eclipse qPCR probes for use in human in vitro diagnostic tests.

Canon has been awarded US Patent No. 8,466,272, "Probe set and method for identifying HLA allele."
Mamoru Tsukada has been named as inventor on the patent.

GenturaDx has developed a molecular diagnostic system that combines sample preparation and real-time PCR testing on a disposable cartridge in an effort to bring molecular testing to more laboratories at small- and medium-sized hospitals.

The vote of confidence is a stepping stone for the company to seek 510(k) approval for an H1N1 test on its platform; to tackle the point-of-care diagnostic market; and to further develop tests for other infectious diseases.

While the amount of the funding was not disclosed, an official from the investment firm that founded Mirina said that it is sufficient to fund the company's operations for 12 to 15 months.

Yacob Ofer, president of Gamida's diagnostics business, said that the acquisition of NanoChip array assets from Elitech gives the firm the ability to continue to service the "large and growing" number of customers in Israel.

Gamida has acquired the array technology that Elitech bought from Nanogen last year.

IP Roundup

Premium

Nanogen, Universitat Konstanz, the University of Chicago, PerkinElmer, Microsoft, Yeda Research and Development

Pages

The data generated by 100,000 Genomes Project is being housed on military servers due to attacks by hackers, Naked Security reports.

A new poll finds most US adults are not familiar with personalized medicine, according to HealthDay.

Vox reports that the United Nations' Convention on Biological Diversity decided against a gene drive moratorium.

In Science this week: sequencing of neuroblastomas uncovers alterations linked to prognosis, and more.